MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
UTHR United Therapeutics
- 359.580
- -0.580-0.16%
Close Dec 20 16:00 ET
- 359.580
- 0.0000.00%
Post 20:01 ET
16.05BMarket Cap15.80P/E (TTM)
363.900High357.985Low1.01MVolume359.500Open360.160Pre Close363.16MTurnover2.47%Turnover Ratio18.15P/E (Static)44.64MShares417.81552wk High2.63P/B14.72BFloat Cap208.62552wk Low--Dividend TTM40.92MShs Float417.815Historical High--Div YieldTTM1.64%Amplitude4.275Historical Low359.755Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
United Therapeutics Stock Forum
$Nike (NKE.US)$ $Hershey (HSY.US)$ $Yelp Inc (YELP.US)$ $Constellation Energy (CEG.US)$ $United Therapeutics (UTHR.US)$
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting | UTHR Stock News
lol that is a shit ton of inside selling all at the end of June
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3 ...
$CG Oncology (CGON.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Insmed (INSM.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Jaguar Health (JAGX.US)$ Phas...
🇺🇸 Texas Pacific Land $Texas Pacific Land (TPL.US)$ 63.3%
🇸🇪 Evolution $Evotec (EVO.US)$ 59.3%
🇺🇸 CME Group $CME Group (CME.US)$ 57.1%
🇺🇸 Visa $Visa (V.US)$ 55.3%
🇬🇧 Rightmove $RIGHTMOVE ADR (RTMVY.US)$ 54.8%
🇺🇸 Verisign $VeriSign (VRSN.US)$ $50.1%
🇦🇺 Pro Medicus $Pingtan Marine Enterprise (PME.US)$ 49.8%
🇺🇸 NVidia $NVIDIA (NVDA.US)$ 47.3%
🇺🇸 Mastercard $MasterCard (MA.US)$ 45.1%
🇫🇷 GTT $GTT Communications, Inc. (GTTN.US)$ 44.8% ...
Gap Ups
1. $Unum Group (UNM.US)$ - up 5.1%
2. $Generac (GNRC.US)$ - up 5.0%
3. $Builders FirstSource (BLDR.US)$ - up 4.9%
4. $Livent (LTHM.US)$ - up 4.4%
5. $Pearson (PSO.US)$ - up 4.1%
6. $Verisk Analytics (VRSK.US)$ - up 3.6%
7. $Assurant (AIZ.US)$ - up 2.7%
8. $Vodafone (VOD.US)$ - up...
No comment yet